PNC Financial Services Group Inc. Purchases 1,439 Shares of Teladoc Health, Inc. (NYSE:TDOC)

PNC Financial Services Group Inc. raised its position in shares of Teladoc Health, Inc. (NYSE:TDOC) by 22.0% in the fourth quarter, HoldingsChannel reports. The firm owned 7,978 shares of the health services provider’s stock after buying an additional 1,439 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Teladoc Health were worth $73,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Whipplewood Advisors LLC bought a new stake in Teladoc Health during the fourth quarter valued at approximately $29,000. Versant Capital Management Inc grew its position in shares of Teladoc Health by 313.8% during the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock valued at $29,000 after acquiring an additional 2,441 shares during the period. Lindbrook Capital LLC increased its stake in shares of Teladoc Health by 78.9% in the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider’s stock worth $33,000 after purchasing an additional 1,612 shares in the last quarter. KBC Group NV lifted its position in Teladoc Health by 72.3% during the fourth quarter. KBC Group NV now owns 8,849 shares of the health services provider’s stock valued at $80,000 after purchasing an additional 3,714 shares in the last quarter. Finally, Westside Investment Management Inc. lifted its position in Teladoc Health by 43.8% during the fourth quarter. Westside Investment Management Inc. now owns 9,200 shares of the health services provider’s stock valued at $84,000 after purchasing an additional 2,800 shares in the last quarter. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Teladoc Health Stock Down 1.9 %

Shares of TDOC opened at $8.65 on Wednesday. The business’s 50 day simple moving average is $10.39 and its 200-day simple moving average is $9.78. Teladoc Health, Inc. has a 1 year low of $6.76 and a 1 year high of $15.43. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The stock has a market capitalization of $1.50 billion, a price-to-earnings ratio of -1.50 and a beta of 1.27.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The business had revenue of $640.49 million during the quarter, compared to analysts’ expectations of $639.44 million. As a group, equities analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, insider Adam C. Vandervoort sold 11,011 shares of the stock in a transaction on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the sale, the insider now owns 64,308 shares of the company’s stock, valued at approximately $541,473.36. This represents a 14.62 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.95% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on TDOC shares. Bank of America raised their price objective on Teladoc Health from $11.50 to $13.50 and gave the stock a “neutral” rating in a research note on Wednesday, February 12th. Piper Sandler dropped their price target on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a research report on Thursday, February 27th. Royal Bank of Canada increased their price objective on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Oppenheimer lowered their target price on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a research note on Friday, January 24th. Finally, The Goldman Sachs Group cut their price target on Teladoc Health from $16.00 to $13.00 and set a “buy” rating for the company in a research note on Monday, March 3rd. Eleven research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, Teladoc Health currently has an average rating of “Hold” and an average target price of $11.26.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.